Neuropsychological Consultation as Part of Pediatric Diabetes Care: Does it Improve Glycemic Control and Family Functioning?
Not Applicable
Completed
- Conditions
- GlycinemiaDiabetes
- Interventions
- Behavioral: Usual standard of careBehavioral: Neuropsychological Consultation
- Registration Number
- NCT03653013
- Lead Sponsor
- NYU Langone Health
- Brief Summary
This is a randomized controlled open label study design (study team will not be blinded) to measure whether including targeted neuropsychological consultations as part of pediatric diabetes care informs treatment and educational planning, improves glycemic control, and improves quality of life. Patients will be randomized 1:1 ratio to Group 1-Control group and Group 2-Neuropsychological consultation group.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 50
Inclusion Criteria
- diagnosed with type 1 diabetes and followed for their care at the NYU pediatric diabetes center
- English speaking families
Read More
Exclusion Criteria
- not english speaking
- diagnosed with type 1 diabetes within the last 6 months
Read More
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description Control Group Usual standard of care Usual standard of care from their diabetes care team Neuropsychological Consultation Group Neuropsychological Consultation Children will be administered a number of neuropsychological tests. Children and parents in Group 2 will also complete a pediatric quality of life scale (PedsQL, Generic Scale and Diabetes Module), diabetes related family conflict scale (DFCS-R) to assess quality of life and family stress at the start of the study, as well as the self-report form of the BRIEF-2 if they are over age 11. Parents will also undergo a brief literacy and numeracy screening using the Wide Range Achievement Test, complete a parent report assessing their children's executive functioning skills at the start of the study (BRIEF-2) and they will fill out the Family Impact Module.
- Primary Outcome Measures
Name Time Method Improved Glycemic Control measured by assessment of glycemic control (HgbA1C) 9 Months
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
NYU Langone Health
🇺🇸New York, New York, United States